Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hematology/Pathology Devices Panel

This article was originally published in The Gray Sheet

Executive Summary

FDA advisory panel meeting August 5 in Rockville, Maryland. Open committee discussion will cover a "points-to-consider document for automated cervical cancer slide readers and automated cervical cancer slide preparation instruments"; "home-use prothrombin time tests"; "standardization of coagulation assays and reagents"; "hematology replacement reagents"; and "a briefing on the FDA Immunohistochemical Products Workshop" held June 28-29. The panel will discuss general issues related to prothrombin time tests, not specific premarket approval applications, FDA says. For more information, call Larry Brindza at 301/594-2096



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts